Join the Acute Coronary Syndrome group to help and get support from people like you.
Acute Coronary Syndrome News
Stroke Risk From Neck Artery Tears Is Rising Fast
THURSDAY, April 3, 2025 – Strokes caused by an artery tear are landing five times as many Americans in the hospital these days, a new study says. Cervical artery dissection involves a small tear in...
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
WEDNESDAY, Feb. 19, 2025 – For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor...
SARS-CoV-2 Infection Linked to More Rapid Plaque Growth in Lesions
MONDAY, Feb. 10, 2025 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque volume, according to a...
Primary Prevention Aspirin Use Decreased After Recommendation Change
FRIDAY, Jan. 24, 2025 – Among older adults and adults with low atherosclerotic cardiovascular disease (ASCVD) risk for whom aspirin is not recommended, use of aspirin decreased after 2019 changes in...
Coronary Artery Disease Common in Patients With Cirrhosis
FRIDAY, Dec. 20, 2024 – Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review...
CORSWO Model Stratifies Women According to Coronary Risk
FRIDAY, Dec. 13, 2024 – The Coronary Risk Score in Women (CORSWO) can predict the risk of major adverse cardiovascular events (MACE), according to a study published online Dec. 5 in Radiology:...
Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina
MONDAY, Nov. 11, 2024 – Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, researchers...
Orbital Atherectomy No Better Than Balloon Angioplasty
MONDAY, Nov. 4, 2024 – For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent implantation does not yield greater minimal stent...
Black Patients 22% More Likely to Die After Bypass Surgeries
TUESDAY, Oct. 22, 2024 – Heart bypass operations have gotten safer, but not everyone is benefiting equally: New data shows that Black patients face a 22% higher odds of dying in the hospital after...
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
TUESDAY, Sept. 17, 2024 – For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC),...
Heart Surgery for Older Women Is Often Risky Business, Study Finds
FRIDAY, July 12, 2024 – Older women are more likely than older men to die following heart bypass surgery, possibly due to the quality of the hospitals where they undergo the procedure, a new study...
Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
WEDNESDAY, May 22, 2024 – Ongoing leisure-time physical activity, even at high volumes, is not associated with coronary artery calcium (CAC) progression, a marker of atherosclerotic cardiovascular...
Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease
June 1, 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most ...
FDA Medwatch Alert: Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 - Due to Report of Another Medicine in One Bottle
ISSUE: AstraZeneca is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of Brilinta (ticagrelor) 90mg...
FDA Approves Expanded Indication for Brilinta to Include Long-Term Use in Patients with a History of Heart Attack
Thursday, 3 September 2015 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60mg dose to be used in patients with a...